Delex Therapeutics, YM BioSciences deal

Cancer company, YM, plans to acquire pain company, Delex in a stock deal. YM will issue 1.6 million shares, which is worth $3.9 million using the company's April 12 close of $2.45 on AMEX. Additionally, YM will issue tranches of 456,000 shares at 6, 12, 18 and 24 months after the deal closes. YM also will issue 2.8 million shares if certain milestones are met. ...